Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam D. Cutler currently holds 99,290 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam D. Cutler has been a net seller of NAVB stock. They have purchased $0 and sold $14.9K worth of shares.
Adam D. Cutler's most recent insider trade was on Dec 5, 2025, when they sold 99,290 shares at $0.00 per share.
Adam D. Cutler serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have executed 7 insider transactions totaling $14.9K over their tenure at the company.
Adam D. Cutler holds the position of Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Adam D. Cutler has shown a selling trading pattern, with $0 in total purchases and $14.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam D. Cutler was on Nov 3, 2025, when they sold $14.9K worth of MURA shares. This transaction involved 7,148 shares at $2.09 per share.
Adam D. Cutler currently owns 99,290 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam D. Cutler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam D. Cutler has 7 Form 4 filings on record as an insider at NAVIDEA BIOPHARMACEUTICALS, INC..
Set alerts for Adam D. Cutler and 40,000+ other insiders.